Volpara Health Technologies Limited
VPAHF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | $33 | $24 | $18 | $12 |
| % Growth | 35% | 33.9% | 47.1% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $30 | $22 | $17 | $11 |
| % Margin | 92.5% | 91.2% | 91.4% | 86% |
| R&D Expenses | $17 | $16 | $13 | $11 |
| G&A Expenses | $12 | $11 | $12 | $12 |
| SG&A Expenses | $27 | $25 | $23 | $25 |
| Sales & Mktg Exp. | $14 | $13 | $11 | $13 |
| Other Operating Expenses | $3 | $3 | $1 | $2 |
| Operating Expenses | $48 | $44 | $39 | $37 |
| Operating Income | -$10 | -$15 | -$17 | -$22 |
| % Margin | -31.4% | -61.3% | -95.2% | -175.6% |
| Other Income/Exp. Net | $1 | $3 | $2 | $2 |
| Pre-Tax Income | -$11 | -$15 | -$17 | -$22 |
| Tax Expense | -$1 | $0 | -$1 | -$2 |
| Net Income | -$9 | -$15 | -$16 | -$20 |
| % Margin | -28% | -63% | -88.6% | -160.9% |
| EPS | -0.036 | -0.061 | -0.065 | -0.094 |
| % Growth | 40.1% | 6.3% | 31.2% | – |
| EPS Diluted | -0.036 | -0.061 | -0.065 | -0.094 |
| Weighted Avg Shares Out | 252 | 251 | 247 | 210 |
| Weighted Avg Shares Out Dil | 252 | 251 | 247 | 210 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $4 | $3 | $2 |
| EBITDA | -$7 | -$14 | -$17 | -$19 |
| % Margin | -20.8% | -57.1% | -92% | -158.2% |